Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 8/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 7/20 | 0.48 |
| ▸ | CA1 | P00915 | 6/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17005596 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL17005588 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL17005594 | 0.92 | CYP2D6 (0.57) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL16136863 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL22330671 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL23266161 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL7152247 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL21945978 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL133205 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL10109449 | 0.89 | CYP2D6 (0.73) | CYP2D6THRBHSD17B10CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228725-A1 | DRUG DELIVERY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-07-29 | — | — | US | disclosed |
| US-10016518-B2 | Inflammation imaging and therapy | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2018-07-10 | — | — | US | disclosed |
| US-20150231281-A1 | INFLAMMATION IMAGING AND THERAPY | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228725-A1 | DRUG DELIVERY | VAPB, CHMP4B, VAPA | CYP2D6 2742/4885THRB 1348/4885HSD17B10 1170/4885 |
| US-20150231281-A1 | INFLAMMATION IMAGING AND THERAPY | LGALS1, SSB, SIGLEC7 | CYP2D6 4709/4885THRB 1262/4885HSD17B10 3444/4885 |
| US-10016518-B2 | Inflammation imaging and therapy | LGALS1, SSB, SIGLEC7 | CYP2D6 4709/4885THRB 1262/4885HSD17B10 3444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.